The 78 references in paper I. Kayukov G., A. Smirnov V., V. Sedov M., Lhaahuu Od-Erdene , A. Dulaev V., V. Pizin M., И. Каюков Г., А. Смирнов В., В. Седов М., Лхаахуу Од-Эрдэне, А. Дудаев В., В. Пизин М. (2008) “СОСТОЯНИЕ ФУНКЦИИ ПОЧЕК У МУЖЧИН С КОРОНАРНОЙ БОЛЕЗНЬЮ СЕРДЦА // THE STATE OF RENAL FUNCTION IN MALES WITH CORONARY HEART DISEASE” / spz:neicon:nefr:y:2008:i:3:p:36-55

1
Lindner A, Charra B, Sherrard DJ. Accelerated Atherosclerosis in prolonged maintenance hemodialysis. N Eng J Med 1974; 290: 697-701
(check this in PDF content)
2
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
(check this in PDF content)
3
Dhingra H, Zaski ME. Outcomes research in dialysis. Semin Nephrol 2003; 23: 295-305
(check this in PDF content)
4
Cheung AK, Sarnak MJ, Jan G et al. Atherosclerotic cardiovascular disease in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
(check this in PDF content)
5
Joki N, Hase H, Nakamura R, Jamaguchi T. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723
(check this in PDF content)
6
Смирнов АВ. Дислипопротеидемии и проблемы нефропротекции. Нефрология 2002; 6(2): 8-14
(check this in PDF content)
7
Jungers P, Massy Z, Khoa T et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
(check this in PDF content)
8
Shoji T, Emoto M, Tabata T et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 2002; 61: 2187-2192
(check this in PDF content)
9
Руденко ТЕ, Кутырина ИМ, Кушнир ВВ, Швецов МЮ. Факторы, влияющие на состояние комплекса интима-ме­ диа сонных и бедренных артерий в начальных стадиях хро­ нической почечной недостаточности. Тер арх 2005; (6): 46-50
(check this in PDF content)
10
Mann JFE, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of Ramipril: the HOPE randomized trial. Ann Int Med 2001; 134: 629-636
(check this in PDF content)
11
McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end- stage renal disease. J Am Soc Nephrol 2004; 15: 1912-1919
(check this in PDF content)
12
Al-Ahmat A, Hand WM, Maanjuna G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular disfunction. J Am Col Cardiol 2001; 38: 955-962
(check this in PDF content)
13
Shlipak MG, Smith GZ, Rathore SS et al. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention droup trial. J Am Soc Nephrol 2004; 15: 2195-2203
(check this in PDF content)
14
Anavekar NS, McMurray JJ, Velazguez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295
(check this in PDF content)
15
Hillege HZ, Girbes AR, de Kam PF et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210
(check this in PDF content)
16
Hillege HZ, van Gilst WH, van Veldhuisen DJ et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of AGE inhibition: the CATS randomized trial. Eur Heart J 2003; 24: 412-420
(check this in PDF content)
17
McCullough PA, Soman SS, Shah SS et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Col Cardiol 2000; 36: 679-684
(check this in PDF content)
18
Shlipak M, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555-562
(check this in PDF content)
19
Wright SR, Reeder GS, Herzog CH et al. Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 2002; 137: 563-570
(check this in PDF content)
20
Jones CA. Hypertension and renal dysfunction: NHANES III. J Am Soc Nephrol 2003; 14: S71-S75
(check this in PDF content)
21
Segura J, Campo C, Gil P et al. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol 2004; 15: 1616-1622
(check this in PDF content)
22
Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker of increased risk for stroke. Stroke 1997; 28: 557-563
(check this in PDF content)
23
Seliger SZ, Siscovick DS, Stehman-Breen CO et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol 2004; 15: 1904-1911
(check this in PDF content)
24
Rahman M, Brown CD, Coresh J et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the antihypertensive and lipid-lowering treatment to patients heart attack trial. Arch Intern Med 2004; 164: 969-976
(check this in PDF content)
25
National Kidney Foundation: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002: 39 [Suppl 1]: S1-S266
(check this in PDF content)
26
Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефро­ логия 2002; 6(4): 11-17
(check this in PDF content)
27
Смирнов АВ, Каюков ИГ, Есаян АМ, Добронравов ВА, Кучер АГ, Тугушева ФА. Превентивный подход в совре­ менной нефрологии. Нефрология 2004; 8(3): 7-14
(check this in PDF content)
28
Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
(check this in PDF content)
29
Reddan DN, Szczech LA, Tuttb RH. Chronic kidney disease, mortality and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003; 14: 2373-2380
(check this in PDF content)
30
Manjunath G, Tighiouart H, Coresh J et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-1129
(check this in PDF content)
31
Culleton BF, Larson MG, Evans JC et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 1999; 159: 1785-1790
(check this in PDF content)
32
Nissenson AR, Pereira BJ, Colling AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization Am J Kidney Dis 2001; 37: 1177-1183
(check this in PDF content)
33
Jones CA, McQuillan GM, Kusek JW et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998; 32: 992-999
(check this in PDF content)
34
Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES- III). J Am Soc Nephrol 2002; 13: 1338-1349
(check this in PDF content)
35
Nitsch D, Dietrich DF, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21: 935-944
(check this in PDF content)
36
Ninomija T, Kiyohara J, Kubo M et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama study. Kidney Int 2005; 68: 228-236
(check this in PDF content)
37
Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической болезни почек в Вологодской области. Нефрология 2004; 8(1): 36-41
(check this in PDF content)
38
Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической почечной недостаточности в Северо-Западном регионе России: на пути к созданию ре­ гистра хронической почечной болезни. Тер арх 2004; 76(9): 57-61
(check this in PDF content)
39
Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Эпидемиология и факторы риска хронических болез­ ней почек: региональный уровень общей проблемы. Тер арх 2005; (6): 20-27
(check this in PDF content)
40
Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Распространенность и заболеваемость поздними ста­ диями хронической болезни почек в Республике Тыва. Не­ фрология 9(4): 25-29
(check this in PDF content)
41
Culleton BF, Larson MG, Wilson PWF et al. Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214­ 2219
(check this in PDF content)
42
Garg AX, ClaarkWF, Haynes B, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES-I. Kidney Int 2002; 61: 1486-1494
(check this in PDF content)
43
Wali RK, Henrich WL. Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin 2005; 23, 3: 343­ 362
(check this in PDF content)
44
Munter P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent dealt resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753
(check this in PDF content)
45
Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1983; 80: 435-442
(check this in PDF content)
46
Shlipak MG, Fried LF, Crump C et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002; 62(3):997-1004
(check this in PDF content)
47
Weiner DE, Tighionart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and All- cnuse mortality: a pooled analysis of community- based studies. J Am Soc Nephrol 2004; 15: 1307-1315
(check this in PDF content)
48
Henry RMA, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407
(check this in PDF content)
49
Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction eguation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
(check this in PDF content)
50
Wang JG, Staessen JA, Fagard RH et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001; 37: 1069-1074
(check this in PDF content)
51
Friedman PJ. Serum creatinine: an in dependent predictor of survival after stroke. Intern Med 1991; 229: 175­ 179
(check this in PDF content)
52
Bursztyn M, Ginsberg G, Spilberg O et al. Mortality in the Jerusalem 70-year-olds longitudinal study: does nifedipine have a role? Geriatr NephrolUrol 1999; 9:5-10
(check this in PDF content)
53
Shlipak MG, Sarnak MJ, Katz R et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060
(check this in PDF content)
54
Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305
(check this in PDF content)
55
Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293:1737-1745
(check this in PDF content)
56
White SZ, Cass A, Atkins RG, Chadban SJ. Chronic kidney disease in the general population. Adv Chronic Kidney Dis 2005; 12: 5-13
(check this in PDF content)
57
Trivedi HS, Pang MMH, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients perspectives. Am J Kidney Dis 2002; 39:721-729
(check this in PDF content)
58
Фернадо Мендес Сант’Анна. Коронарграфия при ишемической болезни сердца. В: Солтоски ПР, Караману- кян ХЛ, Салерно ТА, ред. Секреты кардиохирургии. МЕДп- ресс-информ, М., 2005; 55-62
(check this in PDF content)
59
Sullivan DR, Thomas HM, Freedman SB. A new method of coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119(6): 1262-1266
(check this in PDF content)
60
Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606-607
(check this in PDF content)
61
Bigi R, Cortigiani L, Colombo P, Desideri A, Bax JJ, Parodi O. Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions. Heart 2003; 89(9):1009-1013
(check this in PDF content)
62
Norgaz T, Hobikoglu G, Aksu H et al. Retinopathy is related to the angiographically detected severity and extent of coronary artery disease in patients with type 2 diabetes mellitus. Int Heart J 2005;46(4):639-646
(check this in PDF content)
63
Мухин НА, Моисеев ВС, Кобалава ЖД и др. Карди­ оренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх 2004; (6): 39-46
(check this in PDF content)
64
Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардио­ ренальный континуум: патогенетические основы превентив­ ной нефрологии. Нефрология 2005; 9(3): 7-15
(check this in PDF content)
65
Смирнов АВ, Седов ВМ, Лхаахуу Од-Эрдэнэ, Каю­ ков ИГ и др. Снижение скорости клубочковой фильтрации как независимый фактор риска сердечно-сосудистой бо­ лезни. Нефрология 2006; 10(4): 7-17
(check this in PDF content)
66
Perera GA. Hypertensive vascular disease: description and natural history. J Chron Dis 1955; 1: 33-42
(check this in PDF content)
67
Кузьмин ОБ, Пугаева МО, Чуб СВ. Легкая дисфунк­ ция почек у больных с эссенциальной гипертонией: клини­ ческие проявления и лекарственная терапия. Нефрология 2004; 8(3): 15-21
(check this in PDF content)
68
Есаян АМ. Эссенциальная гипертензия с нефропа­ тией. насколько это актуально в наши дни? Нефрология 2008; 12(2):16-23
(check this in PDF content)
69
Fried ZF, Orchard TJ, Kasiske BZ. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260- 269
(check this in PDF content)
70
Schaeffner ES, Kurth T, Curhan GC et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14: 2084- 2091
(check this in PDF content)
71
Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293- 301
(check this in PDF content)
72
Crundy SM, Brewer HB, Cluman JI et al. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute. American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433- 438
(check this in PDF content)
73
Pinto-Sietsma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 17;133(8):585-591
(check this in PDF content)
74
Stuveling EM, Bakker SJ, Hilige HX et al. Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol Dial Transplant 2005; 20: 497- 508
(check this in PDF content)
75
Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663- 1672
(check this in PDF content)
76
Gentil M, Carriazo A, Pavon MI et al. Comparison of survial in continuous ambulatory peritoneal dialysis and hospital hemodialys. A multicentric study. Nephrol Dial Transplant 1991; 6: 444-4 51
(check this in PDF content)
77
Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46 [suppl 48]: S31-S38
(check this in PDF content)
78
Maiorca R, Vonesh EF, Cavalli PL et al. A multicenter selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-127 Поступила в редакцию 20.03.2008 г.
(check this in PDF content)